Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

The Microbiology Testing Market - Worldwide Growth, Trends and Forecasts (2019-2024) - ResearchAndMarkets.com

March 26, 2019

DUBLIN--(BUSINESS WIRE)--Mar 26, 2019--The “Microbiology Testing Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering.

The Microbiology Testing Market is expected to register a CAGR of nearly 9.4% during the forecast period, 2019-2024.

The propelling factors for the growth of the microbiology testing market include technological advancements in microbiology testing, rising incidences of infectious diseases and outbreak of epidemics, growing healthcare expenditure, and rising private-public funding for research on infectious diseases.

Infectious diseases, such as HIV, human papilloma virus (HPV), and hepatitis B and C, are some forms of STDs that are severe and fatal, and thus the increasing incidences of such diseases are increasing the demand for the microbiology testing market. Increasing healthcare expenditure and the presence of better medical infrastructures, such as hospitals and clinical labs, are some other drivers augmenting the growth of the microbiology testing market.

Rapid growth observed in the geriatric population, increasing number of clinical researches in the field of clinical microbiology, rising incidences of infectious diseases, and increased funding, research grants, and public-private investments are some of the factors that are driving the microbiology testing market.

Rapid technological advancements are also being witnessed across the world that are anticipated to drive the microbiology testing market in the upcoming years. There are emerging economies, such as India and China, which may offer new growth opportunities for the microbiology testing market over the forecast period.

Key Market Trends

Diagnostic Holds the Largest Revenue Share in the Applications and is Expected to do Same

The diagnostics segment is expected to account for the largest share of the microbiology testing market. Some of the key factors driving the growth of this segment are the increasing prevalence of infectious diseases, improving healthcare expenditure, and technological advancements.

The pharmaceutical application segment is also expected to dominate due to the presence of well-established and globally accepted regulations, which govern the evaluation of microbial contamination during pharmaceutical manufacturing and raw material sourcing processes.

Europe Holds the Fastest Growth and is Expected to Follow the Same Trend Over the Forecast Period

The European region is expected to show the fastest growth for microbiology testing and is anticipated to contribute notably toward the microbiology testing market over the forecast period. These can be attributed to the presence of advanced healthcare infrastructure in the region, along with various technological advancements witnessed in this region’s healthcare industry.

However, Asia-Pacific is also expected to grow in the upcoming future, due to the expanding R&D and innovative microbiology testing procedures and the increasing number of hospitals and testing laboratories.

Competitive Landscape

The microbiology testing market has witnessed new product launches, mergers and acquisitions, partnerships, joint ventures, and strategies adopted by the major players to gain competitive advantage. The companies are also introducing advanced microbiological automated systems that have high throughputs and are less time-consuming.

Key Topics Covered


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Technological Advancements in Microbiology Testing

4.2.2 Rising Incidences of Infectious Diseases and Outbreak of Epidemics

4.2.3 Growing Healthcare Expenditure

4.2.4 Rising Private-Public Funding for Research on Infectious Diseases

4.3 Market Restraints

4.3.1 Laboratory Reimbursement Issues

4.3.2 High Cost of Microbiology Instruments

4.4 Porters Five Forces Analysis


5.1 By Application

5.1.1 Pharmaceutical Application

5.1.2 Diagnostic Application

5.1.3 Food and Beverage Testing Application

5.1.4 Environmental Application

5.1.5 Cosmetic Application

5.1.6 Other Applications

5.2 By Product

5.2.1 Equipment

5.2.2 Reagent

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle East & Africa

5.3.5 South America


6.1 Company Profiles

6.1.1 Bio-Rad Laboratories Inc.

6.1.2 Abbott Laboratories

6.1.3 Becton Dickinson and Company

6.1.4 F. Hoffmann-La Roche Ltd.

6.1.5 Bruker Corporation

6.1.6 Hologic Corporation

6.1.7 Cepheid Inc.

6.1.8 bioMerieux S.A.

6.1.9 Thermo Fisher Scientific Inc.


For more information about this report visit https://www.researchandmarkets.com/research/h5q4km/the_microbiology?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190326005918/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:In Vitro Diagnostics



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/26/2019 03:11 PM/DISC: 03/26/2019 03:11 PM